Chronic nerve pain affects millions of people worldwide, often making even the gentlest touch feel agonizing. Researchers at Duke University School of Medicine have now identified a potential breakthrough: restoring the energy factories inside damaged nerve cells could provide relief where traditional pain blockers fall short.
The culprit behind much of this suffering appears to be mitochondria, the microscopic structures responsible for generating energy within cells. When these organelles malfunction in damaged nerves, the result is debilitating pain that can spread throughout the body, particularly in the hands and feet where nerve fibers extend farthest.
A new study published in Nature demonstrates that replenishing mitochondria in damaged nerve tissue significantly reduces pain associated with diabetic neuropathy and chemotherapy-induced nerve damage. In some cases, the pain relief persisted for up to 48 hours. Unlike conventional painkillers that simply block pain signals, this approach targets what may be the root cause: restoring the cell's ability to function properly.
Ru-Rong Ji, director of the Center for Translational Pain Medicine at Duke School of Medicine, led the research using both human tissue samples and mouse models. "By giving damaged nerves fresh mitochondria or helping them make more of their own, we can reduce inflammation and support healing," Ji explained. "This approach has the potential to ease pain in a completely new way."
The team discovered that satellite glial cells, which sit alongside and support sensory neurons, naturally transfer healthy mitochondria into these neurons through tiny tunnel-like structures called nanotubes. When this transfer process breaks down, nerve fibers deteriorate and pain symptoms emerge. Researchers found that increasing this mitochondrial sharing in mice reduced pain-related behaviors by as much as 50 percent.
In a separate approach, the team directly injected isolated mitochondria into nerve clusters. The results revealed something crucial: the quality of the donated mitochondria mattered enormously. Healthy mitochondria eased pain, while mitochondria taken from people with diabetes provided no benefit at all.
The researchers also pinpointed a protein called MYO10 as essential for creating the nanotubes that enable mitochondrial movement between cells. This discovery opens the door to potential future treatments that could artificially enhance this natural transfer process.
While more research is needed to fully map how these nanotubes deliver mitochondria within living nerve tissue, the findings reveal a previously overlooked communication network between nerve and glial cells. Rather than merely suppressing pain signals, this pathway offers a way to address chronic nerve pain at its source.
Author Jessica Williams: "This is the kind of discovery that could reshape how we think about treating chronic pain, moving us from band-aid symptom management to actually fixing what's broken inside damaged nerves."
Comments